Abstract

Alzheimers disease (AD) is rapidly grooving incidence that affects millions of people worldwide, therefore there is an immediate need for its early and accurate diagnosis. Many research studies have been performed on possible accurate and reliable diagnostic biomarkers of AD. This review study provides an overview on the cerebrospinal fluid (CSF) proteins that are used as biochemical markers for the early diagnosis of AD and their future prospects, as well as relevant patents.

Keywords: Alzheimer's disease (AD), abeta42, cerebrospinal fluid (CSF), cytochrome C, secretases, tau protein